Carmustine is a nitrosourea alkylating agent that cross-links DNA strands to inhibit replication, used for brain tumours (including glioblastoma), multiple myeloma and Hodgkin lymphoma. Simson Pharma's Carmustine reference standard and impurities support the demanding stability-indicating QC this chemically reactive oncology agent requires.

Simson Pharma Global Ltd. (UK) and Simson Pharma Global LLC (USA) supply high-quality Carmustine Reference Standards, pharmacopoeial reference materials, and its related impurities to pharmaceutical manufacturers, CROs, analytical laboratories, universities, and regulatory organizations worldwide. To service the Europe and America market efficiently, Simson Pharma Limited has set up Simson Pharma Global Ltd. in United Kingdom and Simson Pharma Global LLC in USA respectively.